Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

Published:2013-12-30 Issue:7 Volume:120 Page:1059-1067
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Joseph Richard W.¹,Kapur Payal²,Serie Daniel J.³,Eckel-Passow Jeanette E.⁴,Parasramka Mansi⁵,Ho Thai⁶,Cheville John C.⁶,Frenkel Eugene⁷,Rakheja Dinesh⁸,Brugarolas James⁷⁹,Parker Alexander³

Affiliation:

1. Division of Medical Oncology; Mayo Clinic Florida; Jacksonville Florida

2. Department of Pathology; University of Texas Southwestern Medical Center; Dallas Texas

3. Departments of Health Sciences Research and Medicine; Mayo Clinic Florida; Jacksonville Florida

4. Department of Health Sciences Research; Mayo Clinic Rochester; Rochester Minnesota

5. Division of Cancer Biology; Mayo Clinic Florida; Jacksonville Florida

6. Division of Hematology/Oncology; Mayo Clinic Arizona; Scottsdale Arizona

7. Division of Hematology-Oncology, Department of Internal Medicine, Simmons Comprehensive Cancer Center; University of Texas Southwestern Medical Center; Dallas Texas

8. Department of Pathology and Pediatrics; University of Texas Southwestern Medical Center; Dallas Texas

9. Department of Developmental Biology; University of Texas Southwestern Medical Center; Dallas Texas

Funder

Aacr

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin.,2013

2. PBRM1 and BAP1 as novel targets for renal cell carcinoma;Brugarolas;Cancer J.,2013

3. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network;Hakimi;Clin Cancer Res.,2013